POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $815,081 | +39.5% | 342,471 | +3.1% | 0.00% | – |
| Q2 2023 | $584,366 | -24.8% | 332,026 | +31.7% | 0.00% | – |
| Q1 2023 | $776,616 | +683.8% | 252,148 | +1248.7% | 0.00% | – |
| Q4 2022 | $99,089 | +7.7% | 18,696 | -28.9% | 0.00% | – |
| Q3 2022 | $92,000 | +55.9% | 26,283 | +15.3% | 0.00% | – |
| Q2 2022 | $59,000 | -58.7% | 22,799 | -28.2% | 0.00% | – |
| Q1 2022 | $143,000 | -37.0% | 31,749 | -4.7% | 0.00% | – |
| Q4 2021 | $227,000 | +6.6% | 33,323 | +14.0% | 0.00% | – |
| Q3 2021 | $213,000 | -17.8% | 29,235 | +13.1% | 0.00% | – |
| Q2 2021 | $259,000 | +77.4% | 25,851 | +68.8% | 0.00% | – |
| Q1 2021 | $146,000 | +102.8% | 15,317 | +132.0% | 0.00% | – |
| Q4 2020 | $72,000 | -22.6% | 6,603 | -37.5% | 0.00% | – |
| Q3 2020 | $93,000 | – | 10,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |